Background: The role of subclinical hypothyroidism in the development of depression remains controversial. We examined the prospective association between subclinical hypothyroidism and incident depressive symptoms.
Studies of the association between subclinical hypothyroidism and depressive symptoms have been mostly cross-sectional, and their findings were inconclusive, with some studies reporting a positive association (9, 10) and others no association (11) (12) (13) (14) . Although some cohort studies have evaluated the association between subclinical hypothyroidism and depression (15, 16) , most of these studies focused on elderly populations, and evidence for an association between subclinical hypothyroidism and depression in young and middle-age populations is scarce.
In the present study, we examined the prospective association between subclinical hypothyroidism and incident depressive symptoms in a large cohort of middle-age apparently healthy men and women. We hypothesized that the incidence of depressive symptoms would be greater in those participants with subclinical hypothyroidism than in those with euthyroid function.
Materials and Methods

Study population
The Kangbuk Samsung Health Study is a cohort study of South Korean men and women aged $18 years who have undergone a comprehensive annual or biennial health examination at the Kangbuk Samsung Hospital Total Health Care Center Clinics in Seoul and Suwon, South Korea (17) . Details of the study design have been described previously (17, 18) . More than 80% of participants were employees of various companies and local governmental organizations and their spouses. In South Korea, the Industrial Safety and Health Law requires annual or biennial health screening examinations of all employees, offered free of charge. The remaining participants voluntarily purchased screening examinations at the health screening center.
The present analysis included participants who had undergone at least two comprehensive health examinations between 1 January 2011 and 31 December 2014 (n = 220,545; Fig. 1 ). We excluded participants who had clinically significant depressive symptoms [defined as a Center for Epidemiologic Studies-Depression (CES-D) score .16; n = 32,707], overt hypothyroidism, overt or subclinical hyperthyroidism (n = 24,249), or a history of cancer (n = 5476) at baseline. We further excluded those participants who had not completed the CES-D questionnaire (n = 30,933) and those who did not have thyroid hormone measurements (n = 34,425) or other covariate data (n = 549) available at baseline. The final sample size was 92,206 participants (62,047 men and 30,159 women). The institutional review board of the Kangbuk Samsung Hospital approved the study and waived the informed consent requirement, because we only used de-identified data routinely collected during health screening examinations.
Data collection
Baseline and follow-up examinations were conducted at the clinics of the Kangbuk Samsung Hospital Health Total Health Care Center in Seoul and Suwon. At each comprehensive health examination, we collected data on demographic characteristics, smoking status, alcohol consumption, physical activity, medical history, and medication use through standardized selfadministered questionnaires. Smoking status was categorized as never, former, or current smoker. Current alcohol intake was categorized as none, moderate (#30 g/d for men and #20 g/d for women), or high (.30 g/d for men and .20 g/d for women). The frequency of vigorous physical activity was categorized as 0, 1 to 3, or .3 times weekly.
Height, weight, and sitting blood pressure were measured by trained nurses. The body mass index was calculated as the weight in kilograms divided by the height in meters squared. Hypertension was defined as systolic blood pressure $140 mm Hg, diastolic blood pressure $90 mm Hg, or the current use of antihypertensive medications. Blood specimens were sampled from the antecubital vein after $10 hours of fasting. Diabetes was defined as a fasting serum glucose of $126 mg/dL, a selfreported history of diabetes mellitus, or the current use of antidiabetic medications.
Serum free triiodothyronine (FT3), free thyroxine (FT4), and thyroid-stimulating hormone (TSH) levels were measured using an electrochemiluminescent immunoassay (Roche, Tokyo, Japan) with a lower limit detection of 0.023 pg/dL, 0.26 pg/mL, and 0.005 mIU/mL, respectively. The coefficients of variation for low-and high-quality control specimens were 1.6% to 2.6% and 1.9% to 3.6% for FT4, 1.2% to 3.9% and 1.7% to 4.1% for FT3, and 2.1% to 3.2% and 2.2% to 3.1% for TSH, respectively. The normal range was 0.93 to 1.7 ng/dL for FT4, 2.0 to 4.4 pg/mL for FT3, and 0.25 to 5.0 mIU/mL for TSH. Subclinical hypothyroidism was defined as an FT4 within the normal range and TSH .5.0 mIU/mL. Although subclinical hypothyroidism is commonly defined using a TSH level of $4.5 mU/mL (19), we considered the ethnicity and age of the study participants (Asian midlife subjects) and defined euthyroid status using a TSH reference range of 0.25 to 5.0 mU/mL, as in previous studies of this type of population (20, 21) . Euthyroid status was defined as FT4, FT3, and TSH levels within the corresponding normal range, no self-reported history of thyroid disease, and no current use of thyroid medications.
We used the Korean version of the CES-D scale (22, 23) to evaluate depressive symptoms. The development of clinically significant depressive symptoms was defined as a CES-D score . 16 . This cutoff has been established and validated in previous studies (24) (25) (26) . Because stress could be an important confounder for the development of depressive symptoms, perceived stress was assessed using the stress questionnaire developed and validated for use in the general Korean population by the Korean Center for Disease Control (27) .
Statistical analysis
The study endpoint was the development of incident depressive symptoms. Participants were followed up from the baseline visit to the visit for the development of depressive symptoms or the last available visit. Because incident depressive symptoms occurred at an unknown point between the visit of diagnosis and the previous visit, we used flexible parametric proportional hazards models to account for interval censored events (28) . We first compared the risk of incident depressive symptoms among participants with subclinical hypothyroidism to that of euthyroid participants. We then assessed the doseresponse relationship between thyroid hormone levels and depressive symptoms among euthyroid participants using two approaches. First, we categorized each thyroid hormone into quartiles. Second, we modeled thyroid hormones using restricted quadratic splines with knots at the 5th, 50th, and 95th percentiles of their sample distributions.
To control for potential confounders, we used three multivariable models with a progressive degree of adjustment. The first model was adjusted for age, sex, year of baseline examination, and study center. The second model was further adjusted for body mass index, smoking status, alcohol consumption, vigorous exercise, total cholesterol, high-density lipoprotein cholesterol, triglycerides, hypertension, and diabetes. The third model was further adjusted for stress level.
As a sensitivity analysis, we divided subclinical hypothyroidism by TSH level (#10 mU/mL and .10 mU/mL). We also performed a sensitivity analysis using repeated measurements of thyroid hormones to examine subclinical hypothyroidism status as a time-varying variable using pooled logistic regression. In addition, we performed prespecified subgroup analyses stratified by age (#50 vs .50 years) and sex (male vs female). However, no statistically significant interaction was found (data not shown). All analyses were performed using STATA, version 12 (StataCorp LP, College Station, TX).
Results
The average age 6 standard deviation of the study participants was 39.9 6 6.7 years, and 32.7% were women ( Table 1 ). The average levels of TSH, FT4, and FT3 were 2.2 6 1.5 mlU/mL, 1.3 6 0.2 ng/dL, and 3.2 6 0.4 pg/mL, respectively. The Spearman correlation coefficients between thyroid hormone levels were 20.08 between TSH and FT3, 20.15 between TSH and FT4, and 0.44 between FT3 and FT4. The prevalence of subclinical hypothyroidism at baseline was 4.7%. Participants with subclinical hypothyroidism were slightly older, were more likely to be women, nonsmokers, and nonalcohol users, and to have a lower body mass index, lower stress level, and higher high-density lipoprotein cholesterol level.
During a median follow-up period of 2 years, incident depressive symptoms occurred in 7323 participants. The multivariable-adjusted hazard ratio (HR) for incident depressive symptoms comparing subclinical hypothyroid and euthyroid participants was 0.95 [95% confidence interval (CI), 0.85 to 1.06; Table 2 ]. When further adjusted for stress levels, the HR was 0.97 (95% CI, 0.87 to 1.09). Among the 4384 participants with subclinical hypothyroidism, 326 (7%) had TSH levels .10 mU/mL (range, 5 to 57 mU/mL; 5th to 95th percentile, 5 to 11 mU/mL). In the sensitivity analyses further dividing subclinical hypothyroidism by TSH level, similar associations were found with depression for those with TSH levels #10 and TSH .10 mU/mL (Supplemental Table 1 ). The conclusions were similar when we examined subclinical hypothyroidism status as a time-varying variable (Supplemental Table 2 ).
Similarly, among euthyroid participants (n = 87,822), no apparent association was found between thyroid hormone levels and an increased risk of incident depressive symptoms (Table 3 , Fig. 2 ). In the fully adjusted models, the HRs for incident depressive symptoms comparing the highest and lowest quartiles were 0.92 (95% CI, 0.86 to 0.99; P for trend = 0.09) for TSH, 0.97 (95% CI, 0.90 to 1.05; P for trend = 0.62) for FT4, and 1.00 (95% CI, 0.92 to 1.08; P for trend = 0.76) for FT3.
Discussion
In the present large prospective cohort of middle-age men and women, we found no apparent association between subclinical hypothyroidism and incident depressive symptoms. The lack of association was similar across age and sex groups and was not affected by adjustment for potential confounders.
The association between subclinical hypothyroidism and depression is controversial. In a study of 123 participants with subclinical hypothyroidism and 123 euthyroid controls, the prevalence of depressive symptoms was approximately double among the subclinical hypothyroid group (10) . Positive associations between subclinical hypothyroidism and depression were also observed in another study of 248 elderly outpatients with subclinical hypothyroidism and 203 euthyroid controls with nonthyroidal disease (9) and in a cross-sectional study of 323 elderly subjects (29) . However, more recent studies have found no association between subclinical hypothyroidism and the lifetime development of depression in women (30, 31) . Furthermore, two larger cross-sectional studies of community-dwelling elderly men Data presented as mean 6 standard deviation or n (%).
Abbreviation: HDL, high-density lipoprotein.
(n = 3,932) (11) and of elderly patients in primary care (n = 5,865) (14) did not find an association between subclinical hypothyroidism and depression. Finally, a recent Danish population study (n = 8214) reported that the prevalence of depression was similar in euthyroid individuals and individuals with subclinical hypothyroidism (32) . Very few cohort studies have evaluated the association between subclinical hypothyroidism and depression. Two small prospective studies, one of 606 adults aged 70 to 82 years (19) and another of 599 subjects aged $85 years found no association between thyroid status and depressive symptoms (33) . In addition, in 918 participants aged $65 years, subclinical hypothyroidism was not associated with depression (16) . A recent retrospective cohort study from Korea with younger (mean age 46.9 years) and generally healthy participants found a positive association between TSH levels and the risk of depressive symptoms in women but not in men (34) . In contrast to our analysis, that study used the Beck Depression Inventory (BDI) to assess for depressive symptoms. The BDI emphasizes the cognitive component (35) and the CES-D emphasizes the affective component of depression (23) . The CES-D is generally recommended for primary screening of depression in community settings or in primary care (36) because it has shown greater sensitivity and specificity for the detection of depressive symptoms compared with the BDI (37), for both young (26, 38) and elderly (39) populations. Several previous cross-sectional and cohort studies reporting positive associations between subclinical hypothyroidism and depression, especially the older studies, might have been limited by small sample sizes and/or selection bias. The larger studies, more recent and less prone to biases, have tended to report more negative results. Furthermore, some studies that reported a beneficial effect of thyroid hormone supplementation in the treatment of depression (4, 6, 7) were open label and potentially subject to a number of information and selection biases.
To the best of our knowledge, our study represents the largest prospective cohort study to evaluate the association between subclinical thyroid dysfunction and depressive symptoms. In addition, we included a detailed list of possible confounders such as age, sex, comorbidities, smoking, alcohol, and menopause status for female participants. Furthermore, to the best of our knowledge, ours is the first study to consider the role of stress in the association between thyroid function and depression. Stress might induce a wide variety of neurochemical and hormonal changes, including in the thyroid hormones (40) (41) (42) . Simultaneously, repeated exposure to stressful events is also a potent risk factor for depression (43) (44) (45) . In our analysis, however, further adjustment for stress did not materially change the results.
The present study had several limitations. We used self-reported questionnaires rather than structured clinical interviews for the identification of depressive symptoms. Also, although the CES-D questionnaires are well established for use in population studies and have good correlation with clinical diagnoses of depression (12), we could not exclude the possibility of misclassification of the outcome. Second, the follow-up period for our study was relatively short, although we were able to identify a large number of participants with incident depressive symptoms. It has been suggested that a mean follow-up duration of 3 years would be suitable to assess long-term changes in depressive symptoms (19) . We have continued to follow up the participants, and future analyses with a longer follow-up period might provide additional insight into the longer term consequences of subclinical hypothyroidism. Our analysis did not exclude participants who developed thyroid disease during the follow-up, because this could mediate the development of depression. Future studies should identify the mechanisms involved in the development of depression associated with different thyroid hormone levels. Finally, our study consisted primarily of middle-age generally healthy men and women from Korea. Therefore, our findings might not be generalizable to other ethnic or age groups. Furthermore, most of our participants were workers employed by large companies, which could further limit the generalizability of our findings.
In conclusion, we found no apparent association between subclinical hypothyroidism and incident depressive symptoms in a large prospective cohort of middle-age men and women. Future prospective studies among other ethnic groups and with longer follow-up periods are needed to confirm our findings.
